# Hinge Health Inc. (HNGE) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Technology / Software. Price $92.37, market value $7.5 billion.

## Valuation
- **P/E (trailing): 11.2×**. Hinge Health Inc. trades at 11.2× trailing earnings. The Technology median in the September 2026 study was 32.1×. Forward P/E is 30.2×, higher than trailing, so analysts expect earnings to fall.
- **Price / sales: 10.4×**. Each dollar of revenue is priced at 10.4×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 21.5×**. The shares trade at 21.5× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: 3.9%** (5-yr avg 6.7%). Free cash flow equals 3.9% of the market value, below its five-year average of 6.7%, so the shares are pricier on cash than usual.
- **Earnings yield: 8.9%**. The inverse of the P/E: 8.9% of the price is earned each year.

## Profitability
- **Gross margin: 84.5%**. Hinge Health Inc. keeps 84.5% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 13.0%**. 13.0% of revenue is left after running the business.
- **Net margin: -89.9%**. The company reported a net loss over the last twelve months.
- **Return on equity: -295.7%**. Return on equity is negative because earnings are negative.
- **Return on assets: 14.6%**. Each dollar of assets produces 14.6% of profit.

## Growth
- **Revenue growth (1 yr): 50.6%**. Revenue grew 50.6% over the last year.
- **EPS growth (1 yr): -783.0%**. Earnings per share fell 783.0%, slower than revenue, so margins compressed.

## Financial health
- **Current ratio: 1.47** (quick 1.47). Current assets cover the next year's liabilities 1.47 times.
- **Altman Z-score: 11.19**. A Z-score of 11.19 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Hinge Health Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (15 analysts). 15 analysts cover Hinge Health Inc.; the consensus is buy, with an average price target of $106.47 (+15% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 64.9%** (YTD 98.9%, 3-mo 45.2%). The shares are up 64.9% over twelve months including dividends.
- **From 52-week high: -3.3%** (207.1% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 59**. An RSI of 59 is neutral.
- **Beta (1 yr): 1.19** (volatility 56%). Beta of 1.19 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=HNGE · Page: https://foliofundamentals.com/stocks/hnge

Not investment advice.